Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.

YMI

YM Biosciences (YMI)

YM Biosciences Ordinary Shares (Canada)
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:AMEX:YMI
DataHoraFonteTítuloCódigoCompanhia
22/02/201316:10Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(b) (15-12b)AMEX:YMIYM Biosciences Ordinary Shares (Canada)
21/02/201317:42Edgar (US Regulatory)Report of Foreign Issuer (6-k)AMEX:YMIYM Biosciences Ordinary Shares (Canada)
15/02/201319:24Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)AMEX:YMIYM Biosciences Ordinary Shares (Canada)
15/02/201319:20Edgar (US Regulatory)(F-10POS)AMEX:YMIYM Biosciences Ordinary Shares (Canada)
14/02/201317:18Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)AMEX:YMIYM Biosciences Ordinary Shares (Canada)
14/02/201313:59Edgar (US Regulatory)Order for 40-app and 40-app/a (app Ordr)AMEX:YMIYM Biosciences Ordinary Shares (Canada)
14/02/201313:08Edgar (US Regulatory)Statement of Ownership (sc 13g)AMEX:YMIYM Biosciences Ordinary Shares (Canada)
12/02/201320:25Edgar (US Regulatory)(25-NSE/A)AMEX:YMIYM Biosciences Ordinary Shares (Canada)
12/02/201320:08Edgar (US Regulatory)(25-NSE)AMEX:YMIYM Biosciences Ordinary Shares (Canada)
08/02/201319:15PR Newswire (Canada)Gilead Sciences completes acquisition of YM BioSciencesAMEX:YMIYM Biosciences Ordinary Shares (Canada)
07/02/201310:19PR Newswire (Canada)YM BioSciences Reports Operational and Financial Results for the Second Quarter of Fiscal 2013AMEX:YMIYM Biosciences Ordinary Shares (Canada)
05/02/201313:47PR Newswire (Canada)YM BioSciences Announces Receipt of Final Court Order Approving the Plan of Arrangement with Gilead SciencesAMEX:YMIYM Biosciences Ordinary Shares (Canada)
04/02/201321:47Dow Jones NewsUPDATE: Price Increases Help Gilead's 4th-Quarter SalesAMEX:YMIYM BioSciences Inc.
04/02/201319:57Dow Jones NewsGilead 4th-Quarter Profit Rose 15% On Strong Revenue Growth Led by HIV FranchiseAMEX:YMIYM BioSciences Inc.
31/01/201314:15PR Newswire (Canada)YM BioSciences Shareholders Approve Plan of Arrangement with Gilead SciencesAMEX:YMIYM Biosciences Ordinary Shares (Canada)
18/01/201310:00PR Newswire (Canada)YM BioSciences Inc. Plan of Arrangement with Gilead Sciences, Inc. Endorsed by Leading Independent Proxy Advisors ISS and Gla...AMEX:YMIYM Biosciences Ordinary Shares (Canada)
10/01/201318:40Edgar (US Regulatory)Report of Foreign Issuer (6-K)AMEX:YMIYM Biosciences Ordinary Shares (Canada)
21/12/201215:19PR Newswire (Canada)YM BioSciences Announces Record Date for Previously Announced Plan of ArrangementAMEX:YMIYM Biosciences Ordinary Shares (Canada)
13/12/201206:10ZacksGilead to Buy YM BioSciences - Analyst BlogAMEX:YMIYM Biosciences Ordinary Shares (Canada)
12/12/201215:25Dow Jones NewsUPDATE: Gilead to Pay $510 Million for YM BioSciences to Expand Cancer PortfolioAMEX:YMIYM BioSciences Inc.
12/12/201213:00PR Newswire (Canada)Gilead Sciences to Acquire YM BiosciencesAMEX:YMIYM Biosciences Ordinary Shares (Canada)
12/12/201212:22Dow Jones NewsGilead Agrees to Buy YM BioSciences For $510 MillionAMEX:YMIYM BioSciences Inc.
09/12/201220:15PR Newswire (Canada)YM BioSciences Reports Phase I/II Data for JAK Inhibitor CYT387 in Myelofibrosis at ASH 2012AMEX:YMIYM Biosciences Ordinary Shares (Canada)
03/12/201220:00PR Newswire (Canada)YM BioSciences Reports Divestiture of Nimotuzumab Assets by CIMYMAMEX:YMIYM Biosciences Ordinary Shares (Canada)
20/11/201220:00PR Newswire (Canada)YM BioSciences Announces Election of Dr. Kapil Dhingra to its Board of DirectorsAMEX:YMIYM Biosciences Ordinary Shares (Canada)
09/11/201218:13Edgar (US Regulatory)Definitive Materials Filed by Investment Companies. (497)AMEX:YMIYM Biosciences Ordinary Shares (Canada)
09/11/201210:00PR Newswire (Canada)YM BioSciences Reports Operational and Financial Results for the First Quarter of Fiscal 2013AMEX:YMIYM Biosciences Ordinary Shares (Canada)
05/11/201213:20PR Newswire (Canada)YM BioSciences JAK Inhibitor CYT387 Produces Meaningful Reductions of Splenomegaly and Durable Transfusion Independence Respo...AMEX:YMIYM Biosciences Ordinary Shares (Canada)
21/09/201214:12Edgar (US Regulatory)Annual Report (foreign private issuer) (40-F)AMEX:YMIYM Biosciences Ordinary Shares (Canada)
25/05/201216:59Edgar (US Regulatory)Voluntary supplemental material filed pursuant to Section 11(a) of the Securities Act of 1933 by foreign issuers (SUPPL)AMEX:YMIYM Biosciences Ordinary Shares (Canada)
 Apresentando as notícias mais relevantes sobre:AMEX:YMI